COVID-19 Crisis:No end in sight;Impact to continue for decades to come

Sustained effort needed
‘Once-in-a-century health crisis’
Recommendations
Labels: COVID-19 crisis, Impacts of Corona virus, WHO
A social media blog for news and views
Labels: COVID-19 crisis, Impacts of Corona virus, WHO
Labels: WHO, Younger people and COVID-19
Decades of neglect and underinvestment in addressing people’s mental health needs have been exposed by the COVID-19 pandemic, the UN said on Thursday, in a call for ambitious commitments from countries in the way they treat psychological illness, amid a potential global spike in suicides and drug abuse.
Spearheading the alert ahead of the upcoming World Health Assembly in Geneva, UN Secretary-General António Guterres urged the international community to do much more to protect all those facing mounting mental pressures.
Launching the UN policy brief - COVID-19 And The Need for Action On Mental Health – Mr. Guterres highlighted how those most at risk today, were “frontline healthcare workers, older people, adolescents and young people, those with pre-existing mental health conditions and those caught up in conflict and crisis. We must help them and stand by them.”
That message was echoed by Dévora Kestel, Director, Department of Mental Health and Substance Use at the World Health Organization (WHO).
She pointed to past economic crises that had “increased the number of people with mental health issues, leading to higher rates of suicide for example, due to their mental health condition or substance abuse”.
In a video message, the UN chief highlighted how psychological problems such as depression and anxiety “are some of the greatest causes of misery in our world”.
He noted how throughout his life “and in my own family, I have been close to doctors and psychiatrists treating these conditions”, and how he had become “acutely aware of the suffering they cause. This suffering is often exacerbated by stigma and discrimination.”
According to the UN guidelines, depression and anxiety before the COVID-19 pandemic cost the global economy more than $ 1 trillion per year.
Depression affects 264 million people in the world, while around half of all mental health conditions start by age 14, with suicide the second leading cause of death in young people aged 15 to 29.
The UN paper also highlights a warning from The Lancet Commission On Global Mental Health And Sustainable Development, that “many people who previously coped well, are now less able to cope because of the multiple stressors generated by the pandemic”.
All this is understandable, given the many uncertainties facing people, the UN policy brief notes, before identifying the growing use of addictive coping strategies, including alcohol, drugs, tobacco and online gaming.
In Canada, one report indicated that 20 per cent of the population aged 15-49 have increased their alcohol consumption during the pandemic.
“During the COVID-19 emergency, people are afraid of infection, dying, and losing family members”, the UN recommendations explain. “At the same time, vast numbers of people have lost or are at risk of losing their livelihoods, have been socially isolated and separated from loved ones, and, in some countries, have experienced stay-at-home orders implemented in drastic ways.”
Specifically, women and children are at greater physical and mental risk as they have experienced increased domestic violence and abuse, the UN paper affirms.
At the same time, misinformation about the virus and prevention measures, coupled with deep uncertainty about the future, are additional major sources of distress, while “the knowledge that people may not have the opportunity to say goodbye to dying loved ones and may not be able to hold funerals for them, further contributes to distress”.
National data from populations around the world would appear to confirm this increased mental vulnerability, WHO’s Dévora Kestel said, citing surveys “showing an increase of prevalence of distress of 35 per cent of the population surveyed in China, 60 per cent in Iran, and 45 per cent in the US”.
Much higher levels of depression and anxiety than normal were also recorded in Ethiopia’s Amhara Regional State last month, the WHO official continued, pointing to the estimated 33 per cent prevalence rate of symptoms - a three-fold increase compared to pre-pandemic levels.
General symptoms caused by COVID-19 include headaches, impaired sense of smell and taste, agitation, delirium and stroke, according to the UN paper.
Underlying neurological conditions also increase the risk of hospitalization for COVID-19, it notes, while stress, social isolation and violence in the family are likely to affect brain health and development in young children and adolescents.
Social isolation, reduced physical activity and reduced intellectual stimulation increase the risk of cognitive decline and dementia in older adults, it adds.
“We need to make sure that measures are there to protect and promote and care for (the) existing situation right now”, Ms. Kestel said. “This is something that needs to be done in the middle of the crisis, so that we can prevent things becoming worse in the near future.”
Data also confirms that medical professionals and other key workers have experienced significant mental health problems linked to the COVID-19 emergency.
“There were some surveys that were done in Canada where 47 per cent of healthcare workers reported (the) need for psychological support – 47 per cent - so almost half of them”, said Ms. Kestel. “In China, we have different figures for
depression: 50 per cent, anxiety 45 per cent, insomnia 34 per cent. Pakistan also, 42 per cent to…26 per cent.”
The UN is also calling for action on mental health among populations fleeing violence, given that even before the COVID-19 outbreak emerged in China last December, the need for mental health and psychosocial support was “huge”, said Dr Fahmy Hanna, Technical Officer, Department of Mental Health and Substance Use at WHO.
“One in five people in these situations would need mental health and psychosocial support because they would have a mental health condition”, he added. “Yemen is not only the world’s largest humanitarian crisis, it’s also one of the world’s largest mental health crises, with more than seven million people who need mental health support.”
Many countries have shown that it is possible to close mental hospitals once care is available in the community, the UN paper states.
“In all emergencies, not only in COVID, there is a risk of human rights violations in long-term facilities”, said Dr Hanna. “There is a risk also of neglect in emergency situations in these facilities and there is a risk also in situations of disease outbreaks and of pandemic, of exposure of staff and residents to infections.”
A key part of the UN appeal is for mental health care to be incorporated into all Governments’ COVID-19 strategies, given that national average expenditure on it is just two per cent.
Such a move could help countries like South Sudan, “where there is only one mental health professional for every four million people”, said Dr Hanna. “Which basically means that someone living in the north of South Sudan, in a city like Malakal, need to take a trip to Juba, to the capital, of 2,000 miles that take him 30 hours to reach the only available service.”
Labels: Mental health, WHO
Author: Belinda Townsend, ANU
As of 10 May over four million COVID-19 cases had been reported worldwide, with 280,000 confirmed deaths. The pandemic has highlighted the need for strong national health systems and regional infectious disease monitoring. Rising global health tensions urge the need for governments to prioritise international mechanisms that promote affordable access to new treatments and vaccines.
As China reports fewer cases of COVID-19, it is seeking to portray itself as a global health leader by supplying medical experts, equipment and resources overseas. Chinese President Xi Jinping has expressed China’s ambition for a ‘Health Silk Road’ with partner countries of its Belt and Road Initiative (BRI). On 21 March China sent 100,000 medical masks and 776 protective suits to Spain via existing BRI railway infrastructure.
China’s Health Silk Road has its origins in a 2015 three-year plan for health cooperation as part of its broader BRI agenda. The original plan included establishing health cooperation mechanisms between BRI countries and projects for infectious disease prevention and treatment. The plan was supported by the World Health Organization (WHO) which entered into a strategic partnership with China in early 2017 ‘to target vulnerable countries on the Belt and Road and Africa’. But despite signing numerous bilateral cooperation agreements with Silk Road countries, there is little to show for it yet.
China’s moves to reassert the Health Silk Road in response to COVID-19 reflects an attempt at reframing the country’s image — from the source of the virus to being a good international citizen. However, this has been met with increasing criticism by the United States, which has alleged that China delayed reporting on the severity of the virus to stockpile medical equipment.
The WHO has also become embroiled in US-China tensions. On 14 April, US President Donald Trump launched an attack on the WHO’s handling of the virus and announced a funding freeze pending review. Two weeks later, US officials presented G7 partners with a list of reforms it wanted the WHO to make. More recently, US Secretary of State Mike Pompeo claimed that the US has proof that the virus originated from a laboratory in China. The WHO and the wider intelligence community have reported that there is no evidence to substantiate these claims.
These US criticisms of the WHO and China have coincided with the United States becoming the country with the highest number of confirmed COVID-19 cases and deaths, amid global criticism for its own slow response to testing, treatment and prevention. A leaked US Republican Party memo reveals that shifting the blame is an explicit party strategy.
Trump’s attack on the WHO is a significant concern for the future of global health. The United States is the WHO’s largest donor, contributing 14.67 per cent to its 2018–2019 budget. By withholding funding from the organisation tasked with helping countries to contain the pandemic, this decision could cost lives. Richard Horton, editor-in-chief of the prestigious medical journal The Lancet has gone further, labelling Trump’s decision ‘a crime against humanity’.
The funding freeze also reveals deeper issues regarding the organisation’s control over funding. The WHO has become more reliant on voluntary contributions from rich member states and global health partners — the Bill and Melinda Gates Foundation is its second-biggest funder — which are often tied to donors’ pet projects. Assessed contributions (amounts paid by each member state calculated by wealth and population) are not tied to specific donors’ projects, but they have fallen to less than 25 per cent of the budget due to a longstanding freeze on payments levels.
This means that the WHO has less power to direct where money is spent and, as a consequence, some important health issues such as addressing the social determinants of health are underfunded. Public health groups have long called for an increase in member states’ assessed contributions to provide more flexible funding that can be directed where it is needed. Now is not the time to cut funding.
Another emerging tension is the question of who pays and who can access new treatments and vaccines for COVID 19. This reflects longstanding battles over the rules and norms governing pharmaceutical research and development and debates about mechanisms to enable low- and middle-income countries to affordably access treatments. In the context of COVID-19, public health groups have intensified calls for mechanisms that ensure equitable and affordable access to vaccines and treatments when they become available.
One such mechanism recently proposed by the Costa Rican government is a voluntary ‘pool’ for sharing rights to technologies for the detection, prevention, control and treatment of COVID-19. The proposal would create a voluntary ‘pool’ of monopoly rights (such as patents and regulatory test data) for tests, vaccines and diagnostics, with either free access or licensing ‘on reasonable and affordable terms, in every member country’.
The proposal has received support from over 150 public health and civil society organisations as well as the European Union. On 6 April, WHO Director-General Tedros Adhanom Ghebreyesus also voiced support for the mechanism, stating that the WHO was ‘working with Costa Rica to finalise the details’.
It is perhaps a coincidence that Trump’s announcement to withhold funding from the WHO came eight days later. But the United States has a long, documented history of pressuring other countries to introduce rules to extend monopolies for pharmaceuticals. The potential costs of a vaccine in the United States is being hotly debated, with some politicians pointing to pharmaceutical industry lobbying to prevent price restrictions on a new vaccine.
Notably, the United States did not contribute any funds to a recent virtual fundraising summit hosted by the European Union, where Australia offered AU$352 million (US$226 million) of public funds towards vaccine development.
In exchange for this significant public expenditure on vaccine and treatment, governments must voice support for mechanisms that promote affordable access, like Costa Rica’s proposal for a voluntary pool of rights. Australia could play a greater role in the region in this regard by voicing support for the voluntary pool at the upcoming World Health Assembly in late May.
Belinda Townsend is a Research Fellow at the School of Regulation and Global Governance and Deputy Director of the Menzies Centre for Health Governance at the Australian National University.
This article is part of an EAF special feature series on the novel coronavirus crisis and its impact.
Courtesy:East Asia Forum
Labels: Global health amid covid-19, WHO